December 19, 2025 - CAT V Biotech, Inc

(Company name to be changed, Inc. upon FINRA approval) MIAMI, FL – December 19, 2025 – 4Cable TV International, Inc. (OTC: CATV), (the "Company") today issued a comprehensive strategic update following President Donald J. Trump’s historic signing of an executive order reclassifying marijuana to Schedule III and authorizing a landmark Medicare pilot program for CBD products. As a company with both a cutting-edge biotech division (Atlas) and active plant-touching hemp operations, CATV is uniquely positioned to benefit from this federal shift across its entire value chain. “This executive order is a game-changer for our dual-track strategy,” said Michael Feldenkrais. “By legitimizing cannabis research, the President has accelerated our Atlas division’s path to discovery. Simultaneously, by opening Medicare to CBD reimbursements, he has created an immediate, federally-backed market for our high-quality hemp products. We are moving from the fringes of the health market into the heart of the American healthcare system.” How the Executive Order Directly Benefits CATV Operations: 1. Direct Revenue Growth for Hemp Operations (Medicare Pilot) The executive order authorizes the Centers for Medicare & Medicaid Services (CMS) to launch a pilot program providing millions of seniors with up to $500 per year in reimbursements for doctor-recommended CBD. ● The Benefit: CATV’s plant-touching hemp division will now have access to a massive, federally-subsidized customer base. Seniors—one of the fastest-growing demographics for CBD use—can now access CATV’s quality-controlled products at potentially no out-of-pocket cost, driving significant sales volume. 2. Accelerated Research for the Atlas Division The move to Schedule III officially recognizes the medical utility of the plant, removing the "research gap" that has hindered the industry for 50 years. ● The Benefit: The Atlas division can now conduct genomic and molecular research with far less bureaucratic friction. This reclassification unlocks opportunities for federal grants and institutional partnerships with major universities and hospitals that were previously restricted by the Schedule I stigma. 3. Increased Value of Intellectual Property (IP) By providing a clear, federally-aligned regulatory framework, the executive order significantly de-risks the development of new cannabinoid therapies. ● The Benefit: The proprietary research being conducted within the Atlas division—including its drug discovery and genetic sequencing efforts—is now more valuable to institutional investors and pharmaceutical partners looking for a compliant pathway into the cannabis biotech space. About 4Cable TV International, Inc. (CATV) 4Cable TV International, Inc. (OTC: CATV) is a vertically integrated biotechnology and wellness company. Through its Atlas division and its specialized hemp operations, CATV is dedicated to driving scientific advancement and delivering high-quality, federally-aligned cannabinoid products to the global market. Contact: Michael Feldenkrais info@catvbt.com

$24B

2021 Global CBD Retail Sales

16%

in beverage

20%

in Capsules

40%

in Oils and Edibles

The Industry

4Cable TV International, Inc. (CATV) Announces Multi-Layered Growth Strategy Following Historic Federal Reclassification and Medicare CBD Coverage

About us

Categories